Author Affiliations: Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia.
Tumor necrosis factor (TNF) inhibitor –induced palmoplantar pustulosis (PPP) is an uncommon cutaneous eruption characterized by sterile pustules on the palms and soles, along with hyperkeratosis, erythema, scaling, and fissuring. While some cases can be treated conservatively, a subset of patients present with severe, refractory disease, even after discontinuation of the inciting medication and the addition of systemic biologic agents, resulting in a considerable detriment to their quality of life. We report 2 such cases and our unique treatment approach.
Chu DH, Van Voorhees AS, Rosenbach M. Treatment of Refractory Tumor Necrosis Factor Inhibitor –Induced Palmoplantar Pustulosis: A Report of 2 Cases. Arch Dermatol. 2011;147(10):1228–1230. doi:https://doi.org/10.1001/archdermatol.2011.275
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: